BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 27622944)

  • 1. Nanomaterials for the Treatment of Bacterial Biofilms.
    Wang LS; Gupta A; Rotello VM
    ACS Infect Dis; 2016 Jan; 2(1):3-4. PubMed ID: 27622944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections.
    Makabenta JMV; Nabawy A; Li CH; Schmidt-Malan S; Patel R; Rotello VM
    Nat Rev Microbiol; 2021 Jan; 19(1):23-36. PubMed ID: 32814862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biofilms--a neglected antibacterial target?
    Toney JH
    Curr Opin Investig Drugs; 2007 Aug; 8(8):598-9. PubMed ID: 17668361
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomaterial-based treatments for medical device-associated infections.
    Tran N; Tran PA
    Chemphyschem; 2012 Jul; 13(10):2481-94. PubMed ID: 22517627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
    Huh AJ; Kwon YJ
    J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted, triggered drug delivery to tumor and biofilm microenvironments.
    Benoit DS; Koo H
    Nanomedicine (Lond); 2016 Apr; 11(8):873-9. PubMed ID: 26987892
    [No Abstract]   [Full Text] [Related]  

  • 9. Biofilm-associated infections: antibiotic resistance and novel therapeutic strategies.
    Sun F; Qu F; Ling Y; Mao P; Xia P; Chen H; Zhou D
    Future Microbiol; 2013 Jul; 8(7):877-86. PubMed ID: 23841634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing Bacterial Infections and Biofilm Formation Using Nanoparticles and Nanostructured Antibacterial Surfaces.
    Mi G; Shi D; Wang M; Webster TJ
    Adv Healthc Mater; 2018 Jul; 7(13):e1800103. PubMed ID: 29790304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of treating biofilm-associated bacterial infections.
    del Pozo JL; Patel R
    Clin Pharmacol Ther; 2007 Aug; 82(2):204-9. PubMed ID: 17538551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotargeting of Resistant Infections with a Special Emphasis on the Biofilm Landscape.
    Alabresm A; Chandler SL; Benicewicz BC; Decho AW
    Bioconjug Chem; 2021 Aug; 32(8):1411-1430. PubMed ID: 34319073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoporous Silica-Based Materials with Bactericidal Properties.
    Bernardos A; Piacenza E; Sancenón F; Hamidi M; Maleki A; Turner RJ; Martínez-Máñez R
    Small; 2019 Jun; 15(24):e1900669. PubMed ID: 31033214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic treatment of biofilm infections.
    Ciofu O; Rojo-Molinero E; Macià MD; Oliver A
    APMIS; 2017 Apr; 125(4):304-319. PubMed ID: 28407419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
    Subhaswaraj P; Syed A; Siddhardha B
    Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence-targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms.
    Ruer S; Pinotsis N; Steadman D; Waksman G; Remaut H
    Chem Biol Drug Des; 2015 Oct; 86(4):379-99. PubMed ID: 25589217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of biofilm-associated infections by signaling molecules and nanoparticles.
    Holban AM; Gestal MC; Grumezescu AM
    Int J Pharm; 2016 Aug; 510(2):409-18. PubMed ID: 26945736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial nanomedicine.
    Yacoby I; Benhar I
    Nanomedicine (Lond); 2008 Jun; 3(3):329-41. PubMed ID: 18510428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomaterials as Promising Alternative in the Infection Treatment.
    Vallet-Regí M; González B; Izquierdo-Barba I
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.